Vaccines

>

Latest News

Cidara’s CD388 Demonstrates Up to 76% Protection Against Influenza in Phase 2b NAVIGATE Trial
Cidara’s CD388 Demonstrates Up to 76% Protection Against Influenza in Phase 2b NAVIGATE Trial

June 23rd 2025

Single-dose, non-vaccine antiviral shows significant seasonal prophylactic efficacy and favorable safety profile in over 5,000 healthy adults.

 FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention
FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

June 18th 2025

Estimate Suggests 30% of Americans Express Vaccine Skepticism
Estimate Suggests 30% of Americans Express Vaccine Skepticism

June 18th 2025

Professional Societies Must Address Gaps When Politics Overrides Evidence
Professional Societies Must Address Gaps When Politics Overrides Evidence

June 16th 2025

FDA Expands Moderna’s mRNA-1345 RSV Vaccine to Younger Adults
FDA Expands Moderna’s mRNA-1345 RSV Vaccine to Younger Adults

June 13th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.